Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Bone Marrow Transplantation

Free Subscription Articles published in Biol Blood Marrow Transplant Retrieve available abstracts of 65 articles: HTML format Text format

Single Articles

January 2012
1. ZHANG H , Chen J, Que W
   A Meta-Analysis of Unrelated Donor Umbilical Cord Blood Transplantation versus Unrelated Donor Bone Marrow Transplantation in Acute Leukemia Patients.
   Biol Blood Marrow Transplant. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. CUDDIHY AR , Suterwala BT, Ge S, Kohn LA, et al
   Rapid Thymic Reconstitution Following Bone Marrow Transplantation in Neonatal Mice is VEGF-Dependent.
   Biol Blood Marrow Transplant. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
3. ATSUTA Y , Morishima Y, Suzuki R, Nagamura-Inoue T, et al
   Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia.
   Biol Blood Marrow Transplant. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
4. BARAO I , Alvarez M, Redelman D, Weiss JM, et al
   Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery After Syngeneic Bone Marrow Transplantation.
   Biol Blood Marrow Transplant. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
5. OKADA M , Yoshihara S, Taniguchi K, Kaida K, et al
   Intra-bone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: A phase I study.
   Biol Blood Marrow Transplant. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
6. LI J , Semple K, Suh WK, Liu C, et al
   Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
   Biol Blood Marrow Transplant. 2011;17:962-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. AU BK , Au MA, Chien JW
   Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
   Biol Blood Marrow Transplant. 2011;17:1072-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. BASHIR Q , Andersson BS, Fernandez-Vina M, de Padua Silva L, et al
   Unrelated donor transplantation for acute myelogenous leukemia in first remission.
   Biol Blood Marrow Transplant. 2011;17:1067-71.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. GOUSSETIS E , Paisiou A, Kitra V, Peristeri I, et al
   Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
   Biol Blood Marrow Transplant. 2011;17:1058-66.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. CHU R , Brazauskas R, Kan F, Bashey A, et al
    Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.
    Biol Blood Marrow Transplant. 2011;17:1018-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
11. CAPITINI CM , Davis JP, Larabee SM, Herby S, et al
    Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination.
    Biol Blood Marrow Transplant. 2011;17:790-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. SAEED M , Paulson K, Lambert P, Szwajcer D, et al
    Publication bias in blood and marrow transplantation.
    Biol Blood Marrow Transplant. 2011;17:930-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. WISEMAN DH
    Donor cell leukemia: a review.
    Biol Blood Marrow Transplant. 2011;17:771-89.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. EISSA H , Gooley TA, Sorror ML, Nguyen F, et al
    Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.
    Biol Blood Marrow Transplant. 2011;17:908-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
15. GUERRERO A , Riddell SR, Storek J, Stevens-Ayers T, et al
    Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation.
    Biol Blood Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. MARIOTTI J , Taylor J, Massey PR, Ryan K, et al
    The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection.
    Biol Blood Marrow Transplant. 2011;17:620-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
17. MABED M
    The potential utility of bone marrow or umbilical cord blood transplantation for the treatment of type I diabetes mellitus.
    Biol Blood Marrow Transplant. 2011;17:455-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
18. SEMPLE K , Yu Y, Wang D, Anasetti C, et al
    Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice.
    Biol Blood Marrow Transplant. 2011;17:309-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. PULSIPHER MA , Young NS, Tolar J, Risitano AM, et al
    Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Netw
    Biol Blood Marrow Transplant. 2011;17:291-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. ZILBERBERG J , Friedman TM, Dranoff G, Korngold R, et al
    Treatment with GM-CSF secreting myeloid leukemia cell vaccine prior to autologous-BMT improves the survival of leukemia-challenged mice.
    Biol Blood Marrow Transplant. 2011;17:330-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. TRAN SD , Redman RS, Barrett AJ, Pavletic SZ, et al
    Microchimerism in salivary glands after blood- and marrow-derived stem cell transplantation.
    Biol Blood Marrow Transplant. 2011;17:429-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
22. HORWITZ EM , Horowitz MM, DiFronzo NL, Kohn DB, et al
    Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network.
    Biol Blood Marrow Transplant. 2011;17:192-6.
    PubMed     Text format     Related articles   
    
    
    
    
23. PEREZ RL , Perez-Simon JA, Caballero-Velazquez T, Flores T, et al
    Limbus damage in ocular graft-versus-host disease.
    Biol Blood Marrow Transplant. 2011;17:270-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. ROSENZWAJG M , Dhedin N, Maury S, Bensimon G, et al
    Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.
    Biol Blood Marrow Transplant. 2011;17:265-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. HUANG XJ , Chang YJ
    Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation.
    Biol Blood Marrow Transplant. 2011;17:197-204.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
26. STEPENSKY P , Shapira MY, Balashov D, Trakhtman P, et al
    Bone marrow transplantation for fanconi anemia using fludarabine- based conditioning.
    Biol Blood Marrow Transplant. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. FIELDING AK
    Philadelphia-positive acute lymphoblastic leukemia--is bone marrow transplant still necessary?
    Biol Blood Marrow Transplant. 2011;17.
    PubMed     Text format     Related articles   
    
    
    
    
28. COLONNA L , Sega EI, Negrin RS
    Natural and expanded CD4(+)CD25(+) regulatory T cells in bone marrow transplantation.
    Biol Blood Marrow Transplant. 2011;17.
    PubMed     Text format     Related articles   
    
    
    
    
29. KAMANI N , Lantos JD, Myers D, Kahn JP, et al
    Ethical considerations in pediatric BMT donors and recipients.
    Biol Blood Marrow Transplant. 2011;17.
    PubMed     Text format     Related articles   
    
    
    
    
30. SUTTORP M , Yaniv I, Schultz KR
    Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
    Biol Blood Marrow Transplant. 2011;17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
31. ANDRADE J , Ge S, Symbatyan G, Rosol MS, et al
    Effects of sub-lethal irradiation on patterns of engraftment after murine bone marrow transplantation.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. JAGASIA S , Misfeldt A, Griffith M, Jagasia M, et al
    Age and total-body irradiation in addition to corticosteroid dose are important risk factors for avascular necrosis of the bone.
    Biol Blood Marrow Transplant. 2010;16:1750-1.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
33. KANG HJ , Shin HY, Park JE, Chung NG, et al
    Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
    Biol Blood Marrow Transplant. 2010;16:1582-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
34. BOLANOS-MEADE J , Smith BD, Gore SD, McDevitt MA, et al
    5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. WOOLFREY A , Lee SJ, Gooley TA, Malkki M, et al
    HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category.
    Biol Blood Marrow Transplant. 2010;16:1382-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. NAVARRO WH , Agovi MA, Logan BR, Ballen K, et al
    Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.
    Biol Blood Marrow Transplant. 2010;16:1442-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. DAVIDS MS , Case C Jr, Hornung R 3rd, Chao NJ, et al
    Assessing surge capacity for radiation victims with marrow toxicity.
    Biol Blood Marrow Transplant. 2010;16:1436-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. SCHONBERGER S , Meisel R, Adams O, Pufal Y, et al
    Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
    Biol Blood Marrow Transplant. 2010;16:1428-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. KALWAK K , Porwolik J, Mielcarek M, Gorczynska E, et al
    Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantatio
    Biol Blood Marrow Transplant. 2010;16:1388-401.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
40. BARKER CC , Agovi MA, Logan B, Lazarus HM, et al
    Childhood Obesity and Outcomes after Bone Marrow Transplantation for Patients with Severe Aplastic Anemia.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. MATTE-MARTONE C , Wang X, Anderson B, Jain D, et al
    Recipient B cells are not required for graft-versus-host disease induction.
    Biol Blood Marrow Transplant. 2010;16:1222-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. PULSIPHER MA , Horwitz EM, Haight AE, Kadota R, et al
    Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.
    Biol Blood Marrow Transplant. 2010;16:1212-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
43. MIELCAREK M , Storb R, Georges GE, Golubev L, et al
    Mesenchymal Stromal Cells Fail to Prevent Acute Graft-versus-Host Disease and Graft Rejection after Dog-Leukocyte-Antigen Haploidentical Bone Marrow Transplantation.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. WOODARD P , Carpenter PA, Davies SM, Gross TG, et al
    Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. CHUNG B , Min D, Joo WJ, Krampf MR, et al
    Combined effects of IL-7 and SCF administration on lymphopoiesis after murine bone marrow transplantation.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
46. KASAMON YL , Jones RJ, Gocke CD, Blackford AL, et al
    Extended Follow-Up of Autologous Bone Marrow Transplantation with 4-Hydroperoxycyclophosphamide (4-HC) Purging for Indolent or Transformed Non-Hodgkin's Lymphomas.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. GOYAL RK , Lin Y, Schultz KR, Ferrell RE, et al
    Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
    Biol Blood Marrow Transplant. 2010;16:927-936.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
48. EAPEN M
    Bone marrow or peripheral blood.
    Biol Blood Marrow Transplant. 2010;16:868-9.
    PubMed     Text format     Related articles   
    
    
    
    
49. HU B , He Y, Wu Y, Bao G, et al
    Activated allogeneic NK cells as suppressors of alloreactive responses.
    Biol Blood Marrow Transplant. 2010;16:772-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. KATO K , Cui S, Kuick R, Mineishi S, et al
    Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
    Biol Blood Marrow Transplant. 2010;16:751-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. AL-MOUSA H , Al-Shammari Z, Al-Ghonaium A, Al-Dhekri H, et al
    Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Biol Blood Marrow Transplant. 2010;16:818-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. HAHN T , Zhelnova E, Sucheston L, Demidova I, et al
    A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation.
    Biol Blood Marrow Transplant. 2010;16:801-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
53. LEE WS , Suzuki Y, Graves SS, Iwata M, et al
    Canine Bone Marrow Derived Mesenchymal Stromal Cells Suppress Allo-Reactive Lymphocyte Proliferation in Vitro but Fail to Enhance Engraftment in Canine Bone Marrow Transplantation.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
54. RUBLE K , Hayat M, Stewart KJ, Chen AR, et al
    Bone Mineral Density After Bone Marrow Transplantation in Childhood: Measurement and Associations.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. KASAMON YL , Luznik L, Leffell MS, Kowalski J, et al
    Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.
    Biol Blood Marrow Transplant. 2010;16:482-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
56. LIN YF , Lairson DR, Chan W, Du XL, et al
    The Costs and Cost-Effectiveness of Allogeneic Peripheral Blood Stem Cell Transplantation versus Bone Marrow Transplantation in Pediatric Patients with Acute Leukemia.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. LI M , Sun K, Redelman D, Welniak LA, et al
    The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
58. LIANG Y , Lai Y, Schwarzenberger P, Li Q, et al
    Targeted Agents for CML. Will that be the End of Allogeneic Bone Marrow Transplantation for that Disease?
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. COLLINS NH , Gee AP, Durett AG, Kan F, et al
    The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.
    Biol Blood Marrow Transplant. 2010;16:253-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. ICLOZAN C , Yu Y, Liu C, Liang Y, et al
    T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.
    Biol Blood Marrow Transplant. 2010;16:170-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. MURAMATSU H , Kojima S, Yoshimi A, Atsuta Y, et al
    Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
    Biol Blood Marrow Transplant. 2010;16:231-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
62. SILVA IA , Olkiewicz K, Askew D, Fisher JM, et al
    Secondary Lymphoid Organs Contribute to, but are not Required for the Induction of Graft-versus-Host Responses Following Allogeneic Bone Marrow Transplantation: A shifting paradigm for T cell allo-activation.
    Biol Blood Marrow Transplant. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. MA Q , Gooley TA, Storb RF
    CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease.
    Biol Blood Marrow Transplant. 2010;16:132-3.
    PubMed     Text format     Related articles   
    
    
    
    
64. CHEN X , Das R, Komorowski R, van Snick J, et al
    Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease.
    Biol Blood Marrow Transplant. 2010;16:123-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. YOUNG NS , Bacigalupo A, Marsh JC
    Aplastic anemia: pathophysiology and treatment.
    Biol Blood Marrow Transplant. 2010;16.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: